Deficiency and also transgenic overexpression of Timp-3 both lead to compromised bone mass and architecture in vivo

Behzad Javaheri, Mark Hopkinson, Blandine Poulet, Andrea S. Pollard, Sandra J. Shefelbine, Yu Mei Chang, Philippa Francis-West, George Bou-Gharios, Andrew A. Pitsillides

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)
177 Downloads (Pure)


Tissue inhibitor of metalloproteinases-3 (TIMP-3) regulates extracellular matrix via its inhibition of matrix metalloproteinases and membrane-bound sheddases. Timp-3 is expressed at multiple sites of extensive tissue remodelling. This extends to bone where its role, however, remains largely unresolved. In this study, we have used Micro-CT to assess bone mass and architecture, histological and histochemical evaluation to characterise the skeletal phenotype of Timp-3 KO mice and have complemented this by also examining similar indices in mice harbouring a Timp-3 transgene driven via a Col-2a-driven promoter to specifically target overexpression to chondrocytes. Our data show that Timp-3 deficiency compromises tibial bone mass and structure in both cortical and trabecular compartments, with corresponding increases in osteoclasts. Transgenic overexpression also generates defects in tibial structure predominantly in the cortical bone along the entire shaft without significant increases in osteoclasts. These alterations in cortical mass significantly compromise predicted tibial load-bearing resistance to torsion in both genotypes. Neither Timp-3 KO nor transgenic mouse growth plates are significantly affected. The impact of Timp-3 deficiency and of transgenic overexpression extends to produce modification in craniofacial bones of both endochondral and intramembranous origins. These data indicate that the levels of Timp-3 are crucial in the attainment of functionally-appropriate bone mass and architecture and that this arises from chondrogenic and osteogenic lineages.

Original languageEnglish
Article numbere0159657
JournalPL o S One
Issue number8
Publication statusPublished - 12 Aug 2016


Dive into the research topics of 'Deficiency and also transgenic overexpression of Timp-3 both lead to compromised bone mass and architecture in vivo'. Together they form a unique fingerprint.

Cite this